{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T12:25:18Z","timestamp":1742387118085,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>Toxocara<\/jats:italic> infection is one of the most common neglected infections of poverty and a helminthiasis of global importance. Traditional diagnostic methods such as antibodies detection in serum samples are limited due to cross-reactivity and poor sensitivity. The use of molecular base methods for diagnosis of <jats:italic>Toxocara<\/jats:italic> infection in Iran has not been fully explored. The purpose of the current study was to estimate the prevalence of <jats:italic>Toxocara<\/jats:italic> infection from serum samples of people living with HIV in Alborz province, Iran using serological and molecular methods.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Blood samples were collected from 105 people living with HIV. Epidemiological data of participant were obtained through a structured questionnaire to investigate the risk factors. Patients CD4<jats:sup>+<\/jats:sup> T cell count were recorded. Anti-<jats:italic>Toxocara<\/jats:italic> IgG antibodies were detected by ELISA, with a cut-off point of 11. PCR was performed to detect genetic material of <jats:italic>Toxocara<\/jats:italic> species in the serum samples.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mean CD4<jats:sup>+<\/jats:sup> count in HIV-infected individuals with positive toxocariasis serology was 255.1\u2009\u00b1\u200921.6 cells\/\u00b5L. Seropositivity for <jats:italic>Toxocara<\/jats:italic> species was observed in 12\/105 (11.4%) people living with HIV. Three samples gave positive results on PCR analysis. Based on the data, a statistically significant relationship was found between anti-<jats:italic>Toxocara<\/jats:italic> IgG antibodies seropositivity and underlying conditions (<jats:italic>p<\/jats:italic>\u2009=\u20090.017). No significant statistical association was observed between seropositivity for <jats:italic>Toxocara<\/jats:italic> and gender, age, exposure to domestic animals or pet keeping, education levels, and occupation (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). The findings of PCR confirmed <jats:italic>Toxocara<\/jats:italic> DNA in 3\/12 (25.0%) serum samples.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These findings demonstrated for the first time that people living with HIV from Alborz province, are being exposed to this zoonosis and a relatively high seroprevalence of <jats:italic>Toxocara<\/jats:italic> in HIV\/AIDS people needs comprehensive health education regarding personal hygiene and how to avoid exposure to this parasite infection, especially in people with an impaired immune system.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08250-8","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T09:02:45Z","timestamp":1683104565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Molecular investigation of Toxocara infection from the serum of people living with HIV in Alborz, Iran"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2265-7460","authenticated-orcid":false,"given":"Mohammad","family":"Zibaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Hatami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4026-4110","authenticated-orcid":false,"given":"Farzaneh","family":"Firoozeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Bakhshipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8359-7452","authenticated-orcid":false,"given":"Abolfazl","family":"Miahipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8250-9702","authenticated-orcid":false,"given":"Alireza","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Shokri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,3]]},"reference":[{"key":"8250_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12879-020-4759-8","volume":"20","author":"AV Eslahi","year":"2020","unstructured":"Eslahi AV, Badri M, Khorshidi A, Majidiani H, Hooshmand E, Hosseini H, et al. Prevalence of Toxocara and Toxascaris infection among human and animals in Iran with meta-analysis approach. BMC Infect Dis. 2020;20:20.","journal-title":"BMC Infect Dis"},{"key":"8250_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00436-007-0722-5","volume":"102","author":"S Azizi","year":"2007","unstructured":"Azizi S, Oryan A, Sadjjadi SM, Zibaei M. Histopathologic changes and larval recovery of Toxocara cati in experimentally infected chickens. Parasitol Res. 2007;102:47\u201352.","journal-title":"Parasitol Res"},{"key":"8250_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/microorganisms10020241","volume":"10","author":"JF Magnaval","year":"2022","unstructured":"Magnaval JF, Bouhsira E, Fillaux J. Therapy and prevention for human toxocariasis. Microorganisms. 2022;10:241.","journal-title":"Microorganisms"},{"key":"8250_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2174\/1871523018666181210115840","volume":"18","author":"M Zibaei","year":"2019","unstructured":"Zibaei M, Shayesteh Z, Moradi N, Bahadory S. Human Toxocara infection: allergy and immune responses. Antiinflamm Antiallergy Agents Med Chem. 2019;18:82\u201390.","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"8250_CR5","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/pathogens10080949","volume":"10","author":"E D\u0142ugosz","year":"2021","unstructured":"D\u0142ugosz E, Milewska M, B\u0105ska P. Identification of Toxocara canis antigen-interacting partners by yeast two-hybrid assay and a putative mechanism of these host-parasite interactions. Pathogens. 2021;10:949.","journal-title":"Pathogens"},{"key":"8250_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3390\/microorganisms10010177","volume":"10","author":"P Waindok","year":"2022","unstructured":"Waindok P, Janecek-Erfurth E, Lindenwald DL, Wilk E, Schughart K, Geffers R, Strube C. Toxocara canis- and Toxocara cati-induced neurotoxocarosis is associated with comprehensive brain transcriptomic alterations. Microorganisms. 2022;10:177.","journal-title":"Microorganisms"},{"key":"8250_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12961-017-0178-8","volume":"15","author":"SH Zyoud","year":"2017","unstructured":"Zyoud SH. Global toxocariasis research trends from 1932 to 2015: a bibliometric analysis. Health Res Policy Syst. 2017;15:14.","journal-title":"Health Res Policy Syst"},{"key":"8250_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/bs.apar.2020.01.011","volume":"109","author":"G Ma","year":"2020","unstructured":"Ma G, Rostami A, Wang T, Hofmann A, Hotez PJ, Gasser RB. Global and regional seroprevalence estimates for human toxocariasis: a call for action. Adv Parasitol. 2020;109:275\u201390.","journal-title":"Adv Parasitol"},{"key":"8250_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/tropicalmed4020065","volume":"4","author":"A von Braun","year":"2019","unstructured":"von Braun A, Trawinski H, Wendt S, L\u00fcbbert C. Schistosoma and other relevant helminth infections in HIV-positive individuals-an overview. Trop Med Infect Dis. 2019;4:65.","journal-title":"Trop Med Infect Dis"},{"key":"8250_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1590\/0004-282x20190054","volume":"77","author":"O Herrera Vazquez","year":"2019","unstructured":"Herrera Vazquez O, Romo ML, Fleury A. Neurocysticercosis and HIV infection: what can we learn from the published literature? Arq Neuropsiquiatr. 2019;77:357\u201365.","journal-title":"Arq Neuropsiquiatr"},{"key":"8250_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/00002030-199006000-00004","volume":"4","author":"IH Grant","year":"1990","unstructured":"Grant IH, Gold JW, Rosenblum M, Niedzwiecki D, Armstrong D. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS. 1990;4:519\u201321.","journal-title":"AIDS"},{"key":"8250_CR12","doi-asserted-by":"crossref","unstructured":"Zibaei M, Sadjjadi SM, Karamian M, Uga S, Oryan A, Jahadi-Hosseini SH. A comparative histopathology, serology and molecular study on experimental ocular toxocariasis by Toxocara cati in Mongolian gerbils and Wistar rats. BioMed Res Int. 2013;2013,e109580.","DOI":"10.1155\/2013\/109580"},{"key":"8250_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12917-022-03366-6","volume":"18","author":"M Naderbandi","year":"2022","unstructured":"Naderbandi M, Zibaei M, Haniloo A, Firoozeh F, Hatami Z, Shokri E, et al. Larva migrans in BALB\/c mice experimentally infected with Toxocara cati ensured by PCR assay. BMC Vet Res. 2022;18:257.","journal-title":"BMC Vet Res"},{"key":"8250_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/bs.apar.2020.01.001","volume":"109","author":"EP Carlin","year":"2020","unstructured":"Carlin EP, Tyungu DL. Toxocara: protecting pets and improving the lives of people. Adv Parasitol. 2020;109:3\u201316.","journal-title":"Adv Parasitol"},{"key":"8250_CR15","first-page":"233","volume":"18","author":"M Zibaei","year":"2017","unstructured":"Zibaei M, Sadjjadi SM. Trend of toxocariasis in Iran: a review on human and animal dimensions. Iran J Vet Res. 2017;18:233\u201342.","journal-title":"Iran J Vet Res"},{"key":"8250_CR16","doi-asserted-by":"publisher","first-page":"e3116","DOI":"10.1371\/journal.pntd.0003116","volume":"8","author":"RM Lee","year":"2014","unstructured":"Lee RM, Moore LB, Bottazzi ME, Hotez P. Toxocariasis in North America: a systematic review. PLoS Negl Trop Dis. 2014;8:e3116.","journal-title":"PLoS Negl Trop Dis"},{"key":"8250_CR17","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.parint.2016.09.001","volume":"65","author":"F L\u00f6tsch","year":"2016","unstructured":"L\u00f6tsch F, Oberm\u00fcller M, Mischlinger J, Mombo-Ngoma G, Groger M, Adegnika AA, et al. Seroprevalence of Toxocara spp. in a rural population in central african Gabon. Parasitol Int. 2016;65:632\u20134.","journal-title":"Parasitol Int"},{"key":"8250_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/bs.apar.2020.01.020","volume":"109","author":"CM Chou","year":"2020","unstructured":"Chou CM, Fan CK. Seroprevalence of Toxocara spp. infection in Southeast Asia and Taiwan. Adv Parasitol. 2020;109:449\u201363.","journal-title":"Adv Parasitol"},{"key":"8250_CR19","doi-asserted-by":"publisher","first-page":"e3121","DOI":"10.1371\/journal.pntd.0003121","volume":"8","author":"EV Noormahomed","year":"2014","unstructured":"Noormahomed EV, Nhacupe N, Mascar\u00f3-Lazcano C, Mauaie MN, Buene T, Funzamo CA, et al. A cross-sectional serological study of cysticercosis, schistosomiasis, toxocariasis and echinococcosis in HIV-1 infected people in Beira, Mozambique. PLoS Negl Trop Dis. 2014;8:e3121.","journal-title":"PLoS Negl Trop Dis"},{"key":"8250_CR20","first-page":"109","volume":"16","author":"JH Kim","year":"2017","unstructured":"Kim JH, Sohn J, Hwang DJ. Ocular toxocariasis in an HIV-positive patient. J Optom Contact Lens. 2017;16:109\u201311.","journal-title":"J Optom Contact Lens"},{"issue":"Suppl 7","key":"8250_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1086\/432001","volume":"41","author":"JF Dhainaut","year":"2005","unstructured":"Dhainaut JF, Claessens YE, Janes J, Nelson DR. Underlying disorders and their impact on the host response to infection. Clin Infect Dis. 2005;41(Suppl 7):481\u20139.","journal-title":"Clin Infect Dis"},{"key":"8250_CR22","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.3390\/nu14234970","volume":"14","author":"MN Mpaka-Mbatha","year":"2022","unstructured":"Mpaka-Mbatha MN, Naidoo P, Islam MM, Singh R, Mkhize-Kwitshana ZL. Anaemia and nutritional status during HIV and helminth coinfection among adults in South Africa. Nutrients. 2022;14:4970.","journal-title":"Nutrients"},{"key":"8250_CR23","doi-asserted-by":"publisher","first-page":"910","DOI":"10.4102\/phcfm.v7i1.910","volume":"7","author":"OA Adeleke","year":"2015","unstructured":"Adeleke OA, Yogeswaran P, Wright G. Intestinal helminth infections amongst HIV-infected adults in Mthatha General Hospital, South Africa. Afr J Prim Health Care Fam Med. 2015;7:910.","journal-title":"Afr J Prim Health Care Fam Med"},{"key":"8250_CR24","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3390\/pathogens10121557","volume":"10","author":"K \u0160imekov\u00e1","year":"2021","unstructured":"\u0160imekov\u00e1 K, Soj\u00e1k \u013d, V\u00edchov\u00e1 B, Balogov\u00e1 L, Jaro\u0161ov\u00e1 J, Antolov\u00e1 D. Parasitic and vector-borne infections in HIV-positive patients in Slovakia-evidence of an unexpectedly high occurrence of Anaplasma phagocytophilum. Pathogens. 2021;10:1557.","journal-title":"Pathogens"},{"key":"8250_CR25","first-page":"474","volume":"9","author":"A Rostami","year":"2014","unstructured":"Rostami A, Keshavarz H, Shojaee S, Mohebali M, Memar AR. Frequency of Toxoplasma gondii in HIV positive patients from west of Iran by ELISA and PCR. Iran J Parasitol. 2014;9:474\u201381.","journal-title":"Iran J Parasitol"},{"key":"8250_CR26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/trstmh\/trz082","volume":"13","author":"E Ahmadpour","year":"2019","unstructured":"Ahmadpour E, Pishkarie-Asl R, Spotin A, Samadi Kafil H, Didarlu H, Azadi Y, et al. Sero-molecular evaluation of Toxoplasma gondii infection among HIV-positive patients. Trans R Soc Trop Med Hyg. 2019;13:771\u20135.","journal-title":"Trans R Soc Trop Med Hyg"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08250-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08250-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08250-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T09:06:37Z","timestamp":1683104797000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08250-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,3]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8250"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08250-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2023,5,3]]},"assertion":[{"value":"21 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The human research ethical approval for the study was granted by the Ethical Committee at the University of Medical Sciences in Alborz, and informed consent obtained from the participants prior to data collection (IR.ABZUMS.REC.1400.050). Written informed consent form was received from each study participant (for those under the age of 15 years, written informed consent form was received from their legal guardians). All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"275"}}